{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:07:38Z","timestamp":1791558458178,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA257241"],"award-info":[{"award-number":["R01CA257241"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020797","name":"NanoMedicines Innovation Network","doi-asserted-by":"publisher","award":["2021-RES SI-05"],"award-info":[{"award-number":["2021-RES SI-05"]}],"id":[{"id":"10.13039\/100020797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2017-04501"],"award-info":[{"award-number":["RGPIN-2017-04501"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CIHR PJT-399878"],"award-info":[{"award-number":["CIHR PJT-399878"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22151-7","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T11:53:05Z","timestamp":1760010785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comprehensive analysis of the tumor targeting efficiency of functionalized nanoparticles in an immunocompetent environment"],"prefix":"10.1038","volume":"15","author":[{"given":"Nolan","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasry","family":"Bouzeineddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safara","family":"Holder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Beckham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Basta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devika B.","family":"Chithrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"3","key":"22151_CR1","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/annonc\/mdh097","volume":"15","author":"ME O\u2019Brien","year":"2004","unstructured":"O\u2019Brien, M. E. et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX\/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann. Oncol. 15 (3), 440\u2013449 (2004).","journal-title":"Ann. Oncol."},{"issue":"3","key":"22151_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jconrel.2013.09.026","volume":"172","author":"DL Stirland","year":"2013","unstructured":"Stirland, D. L. et al. Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice. J. Control Release. 172 (3), 1045\u20131064 (2013).","journal-title":"J. Control Release"},{"key":"22151_CR3","doi-asserted-by":"publisher","first-page":"5879","DOI":"10.2147\/IJN.S123437","volume":"12","author":"D Wu","year":"2017","unstructured":"Wu, D. et al. Nanomedicine applications in the treatment of breast cancer: current state of the Art. Int. J. Nanomed. 12, 5879\u20135892 (2017).","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"22151_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","volume":"12","author":"S \u0110or\u0111evi\u0107","year":"2022","unstructured":"\u0110or\u0111evi\u0107, S. et al. Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Delivery Transl. Res. 12(3), 500\u2013525 (2022).","journal-title":"Drug Delivery Transl. Res."},{"key":"22151_CR5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3389\/fphar.2018.00790","volume":"9","author":"S Hua","year":"2018","unstructured":"Hua, S. et al. Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization. Front. Pharmacol. 9, 790 (2018).","journal-title":"Front. Pharmacol."},{"issue":"8","key":"22151_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2217\/nnm-2017-0039","volume":"12","author":"V Agrahari","year":"2017","unstructured":"Agrahari, V. & Hiremath, P. Challenges associated and approaches for successful translation of nanomedicines into commercial products. Nanomed. (London England). 12 (8), 819\u2013823 (2017).","journal-title":"Nanomed. (London England)"},{"issue":"3","key":"22151_CR7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jconrel.2013.09.013","volume":"172","author":"MJ Ernsting","year":"2013","unstructured":"Ernsting, M. J. et al. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J. Control Release. 172 (3), 782\u2013794 (2013).","journal-title":"J. Control Release"},{"issue":"3","key":"22151_CR8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s44222-023-00138-1","volume":"2","author":"H Cabral","year":"2024","unstructured":"Cabral, H. et al. Controlling the biodistribution and clearance of nanomedicines. Nat. Reviews Bioeng. 2 (3), 214\u2013232 (2024).","journal-title":"Nat. Reviews Bioeng."},{"issue":"3","key":"22151_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/receptors3030016","volume":"3","author":"A Prajapati","year":"2024","unstructured":"Prajapati, A. et al. Receptor-Targeted nanomedicine for cancer therapy. Receptors 3 (3), 323\u2013361 (2024).","journal-title":"Receptors"},{"issue":"2","key":"22151_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41580-024-00777-1","volume":"26","author":"MR Chastney","year":"2025","unstructured":"Chastney, M. R. et al. The role and regulation of integrins in cell migration and invasion. Nat. Rev. Mol. Cell Biol. 26 (2), 147\u2013167 (2025).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"22151_CR11","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1091\/mbc.12.9.2699","volume":"12","author":"EB Voura","year":"2001","unstructured":"Voura, E. B. et al. Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. Mol. Biol. Cell. 12 (9), 2699 (2001).","journal-title":"Mol. Biol. Cell"},{"key":"22151_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.12703\/r\/10-45","volume":"10","author":"D Valdembri","year":"2021","unstructured":"Valdembri, D. & Serini, G. The roles of integrins in cancer. Fac. Rev. 10, 45 (2021).","journal-title":"Fac. Rev."},{"issue":"2","key":"22151_CR13","doi-asserted-by":"publisher","first-page":"e6800","DOI":"10.1002\/cam4.6800","volume":"13","author":"H Javid","year":"2024","unstructured":"Javid, H. et al. RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin-RGD interactions. Cancer Med. 13 (2), e6800 (2024).","journal-title":"Cancer Med."},{"issue":"1","key":"22151_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13346-014-0210-2","volume":"5","author":"D Shan","year":"2015","unstructured":"Shan, D. et al. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of \u03b1v\u03b23 integrin-overexpressing breast cancer cells. Drug Delivery Transl. Res. 5(1), 15\u201326 (2015).","journal-title":"Drug Delivery Transl. Res."},{"issue":"5","key":"22151_CR15","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/adhm.201200006","volume":"1","author":"AJ Shuhendler","year":"2012","unstructured":"Shuhendler, A. J. et al. A novel solid lipid nanoparticle formulation for active targeting to tumor \u03b1(v) \u03b2(3) integrin receptors reveals Cyclic RGD as a double-edged sword. Adv. Healthc. Mater. 1(5), 600 (2012).","journal-title":"Adv. Healthc. Mater."},{"key":"22151_CR16","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.2147\/IJN.S137833","volume":"12","author":"PH Wu","year":"2017","unstructured":"Wu, P. H. et al. Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells. Int. J. Nanomed. 12, 5069\u20135085 (2017).","journal-title":"Int. J. Nanomed."},{"issue":"18","key":"22151_CR17","doi-asserted-by":"publisher","first-page":"e1900543","DOI":"10.1002\/adhm.201900543","volume":"8","author":"T Zhang","year":"2019","unstructured":"Zhang, T. et al. Multitargeted nanoparticles deliver synergistic drugs across the Blood\u2013Brain barrier to brain metastases of triple negative breast cancer cells and Tumor-Associated macrophages. Adv. Healthc. Mater. 8 (18), e1900543 (2019).","journal-title":"Adv. Healthc. Mater."},{"issue":"3","key":"22151_CR18","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1166\/jnn.2015.10321","volume":"15","author":"C Cruje","year":"2015","unstructured":"Cruje, C. & Chithrani, B. D. Integration of peptides for enhanced uptake of pegylayed gold nanoparticles. J. Nanosci. Nanotechnol. 15 (3), 2125\u20132131 (2015).","journal-title":"J. Nanosci. Nanotechnol"},{"issue":"3","key":"22151_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/cancers10030084","volume":"10","author":"C Yang","year":"2018","unstructured":"Yang, C., Bromma, K. & Chithrani, D. Peptide mediated in vivo tumor targeting of nanoparticles through optimization in single and multilayer in vitro cell models. Cancers 10 (3), 84 (2018).","journal-title":"Cancers"},{"issue":"20","key":"22151_CR20","doi-asserted-by":"publisher","first-page":"12026","DOI":"10.1039\/C4NR02535K","volume":"6","author":"C Yang","year":"2014","unstructured":"Yang, C. et al. Peptide modified gold nanoparticles for improved cellular uptake, nuclear transport, and intracellular retention. Nanoscale 6 (20), 12026\u201312033 (2014).","journal-title":"Nanoscale"},{"issue":"11","key":"22151_CR21","doi-asserted-by":"publisher","first-page":"2400246","DOI":"10.1002\/smsc.202400246","volume":"4","author":"Y Cui","year":"2024","unstructured":"Cui, Y. et al. Renal clearable H-Dots leveraging ligand complexation for enhanced active tumor targeting. Small Sci. 4 (11), 2400246 (2024).","journal-title":"Small Sci."},{"issue":"1","key":"22151_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12645-023-00228-0","volume":"14","author":"N Jackson","year":"2023","unstructured":"Jackson, N. et al. Dual enhancement in the radiosensitivity of prostate cancer through nanoparticles and chemotherapeutics. Cancer Nanotechnol. 14 (1), 75\u201322 (2023).","journal-title":"Cancer Nanotechnol."},{"issue":"4","key":"22151_CR23","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1021\/ja2084338","volume":"134","author":"CD Walkey","year":"2012","unstructured":"Walkey, C. D. et al. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 134 (4), 2139\u20132147 (2012).","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"22151_CR24","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2217\/nnm.11.19","volume":"6","author":"JV Jokerst","year":"2011","unstructured":"Jokerst, J. V. et al. Nanoparticle pegylation for imaging and therapy. Nanomed. (Lond). 6 (4), 715\u2013728 (2011).","journal-title":"Nanomed. (Lond)"},{"issue":"24","key":"22151_CR25","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1039\/D1NR02065J","volume":"13","author":"L Shi","year":"2021","unstructured":"Shi, L. et al. Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. Nanoscale 13 (24), 1748\u20131764 (2021).","journal-title":"Nanoscale"},{"key":"22151_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99(Pt A)","author":"JS Suk","year":"2016","unstructured":"Suk, J. S. et al. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 99(Pt A), 28\u201351 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"22151_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12989-017-0199-z","volume":"14","author":"AB Engin","year":"2017","unstructured":"Engin, A. B. et al. Mechanistic Understanding of nanoparticles\u2019 interactions with extracellular matrix: the cell and immune system. Part. Fibre Toxicol. 14 (1), 22\u201316 (2017).","journal-title":"Part. Fibre Toxicol."},{"issue":"5","key":"22151_CR28","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.bpj.2010.06.016","volume":"99","author":"T Stylianopoulos","year":"2010","unstructured":"Stylianopoulos, T. et al. Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions. Biophys. J. 99 (5), 1342\u20131349 (2010).","journal-title":"Biophys. J."},{"issue":"1","key":"22151_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s40820-015-0060-6","volume":"8","author":"D Yohan","year":"2016","unstructured":"Yohan, D. et al. Size-Dependent gold nanoparticle interaction at Nano\u2013Micro interface using both monolayer and Multilayer(Tissue-Like) cell models. Nano-micro Lett. 8 (1), 44\u201353 (2016).","journal-title":"Nano-micro Lett."},{"issue":"52","key":"22151_CR30","doi-asserted-by":"publisher","first-page":"51349","DOI":"10.1021\/acsomega.4c08214","volume":"9","author":"B Judmann","year":"2024","unstructured":"Judmann, B. et al. Are 3D tumor cell spheroids a utile system for the in vitro evaluation of diagnostic radiotracers? ACS Omega. 9 (52), 51349\u201351362 (2024).","journal-title":"ACS Omega"},{"issue":"4","key":"22151_CR31","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0002-9440(10)65006-7","volume":"156","author":"H Hashizume","year":"2000","unstructured":"Hashizume, H. et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156 (4), 1363\u20131380 (2000).","journal-title":"Am. J. Pathol."},{"issue":"17\u201318","key":"22151_CR32","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.drudis.2006.07.005","volume":"11","author":"AK Iyer","year":"2006","unstructured":"Iyer, A. K. et al. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today. 11 (17\u201318), 812\u2013818 (2006).","journal-title":"Drug Discov Today"},{"key":"22151_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejpb.2021.05.027","volume":"166","author":"D Fleischmann","year":"2021","unstructured":"Fleischmann, D. & Goepferich, A. General sites of nanoparticle biodistribution as a novel opportunity for nanomedicine. Eur. J. Pharm. Biopharm. 166, 44\u201360 (2021).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"22151_CR34","doi-asserted-by":"publisher","first-page":"114708","DOI":"10.1016\/j.addr.2023.114708","volume":"194","author":"M Kumar","year":"2023","unstructured":"Kumar, M. et al. Nanoparticle biodistribution coefficients: A quantitative approach for Understanding the tissue distribution of nanoparticles. Adv. Drug Deliv. Rev. 194, 114708 (2023).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"22151_CR35","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1021\/acsnano.0c00468","volume":"14","author":"LY Liu","year":"2020","unstructured":"Liu, L. Y. et al. Nanoparticle uptake in a spontaneous and immunocompetent woodchuck liver cancer model. ACS Nano. 14 (4), 4698\u20134715 (2020).","journal-title":"ACS Nano"},{"issue":"46","key":"22151_CR36","doi-asserted-by":"publisher","first-page":"18246","DOI":"10.1039\/C7NR01153A","volume":"9","author":"S Si-Mohamed","year":"2017","unstructured":"Si-Mohamed, S. et al. Evaluation of spectral photon counting computed tomography K-edge imaging for determination of gold nanoparticle biodistribution in vivo. Nanoscale 9 (46), 18246\u201318257 (2017).","journal-title":"Nanoscale"},{"key":"22151_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jconrel.2016.02.011","volume":"227","author":"YW Yang","year":"2016","unstructured":"Yang, Y. W. & Luo, W. H. Cellular biodistribution of polymeric nanoparticles in the immune system. J. Control Release. 227, 82\u201393 (2016).","journal-title":"J. Control Release"},{"issue":"7","key":"22151_CR38","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1172\/JCI45600","volume":"121","author":"M Benezra","year":"2011","unstructured":"Benezra, M. et al. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J. Clin. Invest. 121 (7), 2768\u20132780 (2011).","journal-title":"J. Clin. Invest."},{"issue":"17","key":"22151_CR39","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1016\/j.biomaterials.2011.02.006","volume":"32","author":"X Yang","year":"2011","unstructured":"Yang, X. et al. cRGD-functionalized, DOX-conjugated, and \u2076\u2074Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET\/MR imaging. Biomaterials 32 (17), 4151\u20134160 (2011).","journal-title":"Biomaterials"},{"issue":"1","key":"22151_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4049\/jimmunol.154.1.180","volume":"154","author":"LD Shultz","year":"1995","unstructured":"Shultz, L. D. et al. Multiple defects in innate and adaptive Immunologic function in NOD\/LtSz-scid mice. J. Immunol. (1950). 154 (1), 180\u2013191 (1995).","journal-title":"J. Immunol. (1950)"},{"issue":"1","key":"22151_CR41","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/s42003-021-02611-2","volume":"4","author":"RC Turaga","year":"2021","unstructured":"Turaga, R. C. et al. Targeting integrin alphavbeta3 by a rationally designed protein for chronic liver disease treatment. Commun. Biol. 4 (1), 1087 (2021).","journal-title":"Commun. Biol."},{"issue":"18","key":"22151_CR42","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1016\/j.biomaterials.2011.02.029","volume":"32","author":"SL Bellis","year":"2011","unstructured":"Bellis, S. L. Advantages of RGD peptides for directing cell association with biomaterials. Biomaterials 32 (18), 4205\u20134210 (2011).","journal-title":"Biomaterials"},{"issue":"51","key":"22151_CR43","first-page":"pE10871","volume":"114","author":"AJ Tavares","year":"2017","unstructured":"Tavares, A. J. et al. Effect of removing Kupffer cells on nanoparticle tumor delivery. Proc. Natl. Acad. Sci. - PNAS. 114 (51), pE10871\u2013E10880 (2017).","journal-title":"Proc. Natl. Acad. Sci. - PNAS"},{"issue":"1","key":"22151_CR44","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","volume":"15","author":"IV Zelepukin","year":"2024","unstructured":"Zelepukin, I. V., Shevchenko, K. G. & Deyev, S. M. Rediscovery of mononuclear phagocyte system Blockade for nanoparticle drug delivery. Nat. Commun. 15 (1), 4366\u20134314 (2024).","journal-title":"Nat. Commun."},{"key":"22151_CR45","doi-asserted-by":"publisher","first-page":"177059","DOI":"10.1016\/j.ejphar.2024.177059","volume":"984","author":"J Barilo","year":"2024","unstructured":"Barilo, J. et al. Polarized macrophage functions are affected differentially after CSF-1R Inhibition with PLX5622. Eur. J. Pharmacol. 984, 177059 (2024).","journal-title":"Eur. J. Pharmacol."},{"key":"22151_CR46","doi-asserted-by":"crossref","unstructured":"Alothaimeen, T. et al. Differential TLR7-mediated cytokine expression by R848 in M-CSF- versus GM-CSF-derived macrophages after LCMV infection. J. Gen. Virol.\u00a0102(3) (2021).","DOI":"10.1099\/jgv.0.001541"},{"issue":"1\u20132","key":"22151_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jim.2008.07.009","volume":"338","author":"A Alatery","year":"2008","unstructured":"Alatery, A. & Basta, S. An efficient culture method for generating large quantities of mature mouse Splenic macrophages. J. Immunol. Methods. 338 (1\u20132), 47\u201357 (2008).","journal-title":"J. Immunol. Methods"},{"issue":"6","key":"22151_CR48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/vim.2019.0178","volume":"33","author":"T Alothaimeen","year":"2020","unstructured":"Alothaimeen, T. et al. Granulocyte\/Macrophage Colony-Stimulating Factor-Derived macrophages exhibit distinctive early immune response to lymphocytic choriomeningitis virus infection. Viral Immunol. 33 (6), 477\u2013488 (2020).","journal-title":"Viral Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22151-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22151-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22151-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:44:42Z","timestamp":1768473882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22151-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22151"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22151-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article Safara Holder was incorrectly affiliated with \u2018Department of Physics and Astronomy, University of Victoria, Victoria, BC, Canada\u2019. The correct affiliation is: \u2018Department of Biomedical and Molecular Sciences, Queen\u2019s University, Kingston, ON, Canada\u2019.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35225"}}